- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07556367
Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients
Study Overview
Status
Detailed Description
PRIMARY OBJECTIVES:
I.To describe the baseline knowledge and access to dental care of underinsured/uninsured head and neck cancer patients treated with radiation at University California of San Francisco (UCSF) and Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG).
II.To pilot and characterize the feasibility and outcomes of an in-clinic fluoride varnish dental treatment paired with routine cancer surveillance for post-radiation head and neck cancer patients who do not have reliable access to dental care
III.To develop readily accessible patient educational material for dental care after radiation treatment for HNC.
SECONDARY OBJECTIVES:
I. Explore barriers and facilitators to adapting an integrated preventative fluoride intervention into clinical care for HNC patients through qualitative interviews.
II. Co-design patient advocacy materials and a clinician implementation toolkit to provide a framework for adopting this intervention diverse community-based settings
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94110
- Zuckerberg San Francisco General Hospital (ZSFG)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- >18 years old who are uninsured or underinsured (MediCal, Healthy SF) or have full coverage.
- Patients who have received immunotherapy or enhanced chemotherapy regimens.
- Patients or health and dental care providers who are able to provide their own informed written consent.
Exclusion Criteria:
- >18 years old.
- Patients, caregivers, health and dental care providers who are able to provide their own informed written consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fluoride Varnish Treatment (Participant)
Participants will received Medicom Duraflor Ultra White 5% Sodium Fluoride varnish treatments during their routine cancer surveillance visits every 3-6 month for about 1 year.
During these visits, participants will complete short surveys, provide saliva samples, and have photos taken of their teeth before and after the treatment.
Health and dental care providers will also be asked to complete a survey about fluoride treatment delivered.
|
Participants will complete surveys to collect information about their dental health before and after fluoride varnish treatment.
Healthcare and dental providers will complete a survey to assess the feasibility of the fluoride varnish treatment.
Participants will provide a saliva sample for pH measurement.
Images of participants' teeth will be taken to assess the Decayed, Missing, and Filled Teeth (DMFT) index.
Participants will receive 4-5 fluoride varnish treatment every 3 month over the course of a year.
Treatment is delivered during cancer surveillance visits.
Participant will also receive dental care educational materials.
|
|
Other: Interview
The research team will interviews with participants, caregivers, and healthcare and dental providers.
|
Participants and caregivers will share their experiences accessing dental care, identify barriers to care, and provide their views on integrating preventive dental care into routine medical care.
Healthcare and dental providers will share their observations about patient access to dental care and their views on integrating preventive dental care into routine medical care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean score of Feasibility of Intervention Measure (FIM)
Time Frame: Up to 1 year
|
The Feasibility of Intervention Measure (FIM) is a 4-item implementation measure that assesses participants or providers' perceived feasibility of the intervention.
Responses are rated on a 5-point Likert scale ranging from 1 (Completely Disagree) to 5 (Completely Agree).
The survey is administered at baseline and at each surveillance visit.
|
Up to 1 year
|
|
Interview
Time Frame: Up to one day
|
Interview will be conducted with participants and providers using guided questions.
Responses will be analyzed to assess the feasibility and potential for expanding the fluoride varnish program.
|
Up to one day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Change of Score of Dental Care Practice
Time Frame: Up to 1 year
|
The Dental Care Practices Survey assesses oral health behaviors and dental care utilization, including frequency of dental visits, toothbrushing tools, and flossing practices.
Mean changes in survey scores will be evaluated to assess changes in dental care practices following fluoride varnish treatment and dental health education.
Participants will complete the survey at baseline and at each surveillance visit.
|
Up to 1 year
|
|
Mean Change of Score of Familiarity with the Risks of Radiation
Time Frame: Up to 1 year
|
The Familiarity with the Risks of Radiation Survey assesses knowledge of the effects of head and neck radiation on oral health and attitudes toward seeking dental care.
Mean changes in survey scores will be evaluated to assess changes in knowledge and attitudes following fluoride varnish treatment and dental health education.
Participants will complete the survey at baseline and at each surveillance visit.
|
Up to 1 year
|
|
Change in Saliva potential hydrogen (pH) measure
Time Frame: Up to 1 year
|
Changes in salivary potential hydrogen (pH) will be evaluated to assess changes in oral health status following fluoride varnish treatment and dental health education.
Saliva samples will be collected from participants at baseline and at each surveillance visit, and pH will be measured using a digital pH meter.
|
Up to 1 year
|
|
Mean Change of Score of Oral Health-Related Quality of Life (OHRQoL)
Time Frame: Up to 1 year
|
Participants will complete the Oral Health Impact Profile-14 (OHIP-14) to assess oral health-related quality of life (OHRQoL).
The OHIP-14 is a 14-item questionnaire that measures OHRQoL across seven domains: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap.
Responses are rated on a 5-point Likert scale ranging from 0 (Never) to 5 (Always).
Mean changes in OHRQoL scores will be used to evaluate changes following fluoride varnish treatment and dental health education.
The questionnaire will be completed at baseline and at each surveillance visit.
|
Up to 1 year
|
|
Mean score Change in Decayed-Missing-Filled Teeth (DMFT) Index
Time Frame: Up to 1 year
|
The Decayed, Missing, and Filled Teeth (DMFT) index is measured as the number of decayed, missing, and filled teeth.
Mean changes in DMFT scores will be used to evaluate changes in oral health following fluoride varnish treatment and dental health education.
The DMFT assessment will be performed at baseline and at each surveillance visit.
|
Up to 1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mary J Xu, MD, University of California, San Francisco
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms by Site
- Neoplasms
- Head and Neck Neoplasms
- Health Care Quality, Access, and Evaluation
- Investigative Techniques
- Epidemiologic Methods
- Data Collection
- Health Care Evaluation Mechanisms
- Quality of Health Care
- Public Health
- Environment and Public Health
- Interviews as Topic
- Surveys and Questionnaires
Other Study ID Numbers
- 242010
- NCI-2026-02914 (Registry Identifier: NCI Clinical Trials Reporting System (CTRP))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Cancer
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
Mayo ClinicCompletedCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
West China HospitalNot yet recruitingHead and Neck Cancer | Malignant Neoplasm | Advanced Head and Neck Carcinoma | Head &Amp; Neck Cancer
-
National Cancer Institute (NCI)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
Fondazione IRCCS Policlinico San Matteo di PaviaNestle Health Science; Akern SrlCompletedHead-neck CancerItaly
-
Radboud University Medical CenterUnknown
-
University of California, San FranciscoCompleted
-
Chinook Therapeutics, Inc. (formerly Aduro)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
Uppsala UniversityRegion Östergötland; Region Skane; Region Västerbotten; Swedish Cancer Society; S... and other collaboratorsNot yet recruitingHead and Neck Cancer | Head and Neck Cancer Squamous Cell CarcinomaSweden
Clinical Trials on Surveys
-
Memorial Sloan Kettering Cancer CenterCompletedRectal Cancer | Colon CancerUnited States
-
Richmond University Medical CenterRecruiting
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedEndometrial CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedOvarian CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAlbert Einstein College of Medicine; Virginia Commonwealth University; HHC, Gun... and other collaboratorsCompletedColorectal Cancer ScreeningUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnCancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)
-
Universidad Católica San Antonio de MurciaNot yet recruiting
-
RANDClaremont Graduate UniversityCompleted
-
Elysium HealthUniversity of OxfordNot yet recruitingBiological Aging